Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

William A. Zoghbi, MD, MACC, FAHA, FASE, is the chair of the Department of Cardiology at the Houston Methodist DeBakey Heart and Vascular Center, and past president of both the American College of Cardiology (ACC) and the American Society of Echocardiography (ASE).

VIDEO: New advances in echocardiography

William A. Zoghbi, MD, past president of the ACC and ASE, discussed the latest trends in cardiac ultrasound technology. 

Thumbnail

AI-powered ECG analysis could boost care for patients with hypertrophic cardiomyopathy

Advanced algorithms can pick up on key details in a 12-lead ECG that human readers are unable to see. 

AFib, AI and heart-healthy diets: European Society of Cardiology previews EHRA 2022

The European Heart Rhythm Association's annual conference is headed to Denmark. 

Thumbnail

Screening older patients for AFib during regular care is feasible, but not productive

Screening did provide some value for patients 85 years and older, but more research is still required. 

Thumbnail

DOACs an effective substitute for VKAs after AFib patients undergo bioprosthetic valve replacement

Direct oral anticoagulants are noninferior to vitamin K antagonists when treating this important patient population, researchers reported. 

Evolocumab

Evolocumab limits adverse cardiovascular outcomes among PCI patients

Data from the FOURIER trial helped clinicians learn more about this popular PCSK9 inhibitor.

Thumbnail

Distal radial access consistently lowers risk of artery occlusion during PCI

The new meta-analysis, published in the American Journal of Cardiology, includes data from 16 different studies. 

Doctor patient with masks

Congenital heart disease increases risk of poor COVID-19 outcomes, including death

Researchers examined data from more than 235,000 hospitalized patients treated in the United States.